329 related articles for article (PubMed ID: 9655092)
1. Cardiopulmonary bypass primes polymorphonuclear leukocytes.
Schwartz JD; Shamamian P; Schwartz DS; Grossi EA; Jacobs CE; Steiner F; Minneci PC; Baumann FG; Colvin SB; Galloway AC
J Surg Res; 1998 Mar; 75(2):177-82. PubMed ID: 9655092
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability.
Partrick DA; Moore EE; Fullerton DA; Barnett CC; Meldrum DR; Silliman CC
J Surg Res; 1999 Sep; 86(1):42-9. PubMed ID: 10452867
[TBL] [Abstract][Full Text] [Related]
3. Involvement of platelet-activating factor in endotoxin-induced priming of rabbit polymorphonuclear leukocytes.
Stewart AG; Harris T
J Lipid Mediat; 1991; 3(2):125-38. PubMed ID: 1665713
[TBL] [Abstract][Full Text] [Related]
4. Superoxide responses to formyl-methionyl-leucyl-phenylalanine in primed neutrophils. Role of intracellular and extracellular calcium.
Walker BA; Hagenlocker BE; Ward PA
J Immunol; 1991 May; 146(9):3124-31. PubMed ID: 1849943
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release.
Barnett CC; Moore EE; Partrick DA; Silliman CC
J Surg Res; 1997 Jul; 70(2):166-70. PubMed ID: 9245567
[TBL] [Abstract][Full Text] [Related]
6. Postinjury neutrophil priming and activation: an early vulnerable window.
Botha AJ; Moore FA; Moore EE; Kim FJ; Banerjee A; Peterson VM
Surgery; 1995 Aug; 118(2):358-64; discussion 364-5. PubMed ID: 7638753
[TBL] [Abstract][Full Text] [Related]
7. Lexipafant inhibits platelet activating factor enhanced neutrophil functions.
Schwartz JD; Shamamian P; Grossi EA; Schwartz DS; Marcus SG; Steiner F; Jacobs CE; Tayyarah M; Eng K; Colvin SB; Galloway AC
J Surg Res; 1997 May; 69(2):240-8. PubMed ID: 9224389
[TBL] [Abstract][Full Text] [Related]
8. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
Stewart AG; Harris T; De Nichilo M; Lopez AF
Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872
[TBL] [Abstract][Full Text] [Related]
9. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera.
Samuelsson J; Hansson A; Rosendahl K; Palmblad J
J Lab Clin Med; 1993 Feb; 121(2):310-9. PubMed ID: 8381848
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
Wirthmueller U; De Weck AL; Dahinden CA
J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary and neutrophil responses to priming effects of platelet-activating factor in pigs.
Kruse-Elliott KT
Am J Vet Res; 1997 Dec; 58(12):1386-91. PubMed ID: 9401686
[TBL] [Abstract][Full Text] [Related]
12. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
[TBL] [Abstract][Full Text] [Related]
13. Activation of equine neutrophils by phorbol myristate acetate or N-formyl-methionyl-leucyl-phenylalanine induces a different response in reactive oxygen species production and release of active myeloperoxidase.
Franck T; Kohnen S; de la Rebière G; Deby-Dupont G; Deby C; Niesten A; Serteyn D
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):243-50. PubMed ID: 19328559
[TBL] [Abstract][Full Text] [Related]
14. Mechanism and regulation of neutrophil priming by platelet-activating factor.
Gay JC
J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide is not involved in hepatocyte killing by neutrophils activated by N-formyl-methionyl-leucylphenylalanine or phorbol myristate acetate in vitro.
Wagner JG; Ganey PE; Roth RA
Hepatology; 1996 Apr; 23(4):803-10. PubMed ID: 8666335
[TBL] [Abstract][Full Text] [Related]
16. Priming of neutrophil oxidative responses by platelet-activating factor.
Gay JC
J Lipid Mediat; 1990; 2 Suppl():S161-75. PubMed ID: 1966814
[TBL] [Abstract][Full Text] [Related]
17. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA
J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016
[TBL] [Abstract][Full Text] [Related]
18. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
Stewart AG; Harris T
Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell platelet-activating factor primes neutrophil responses: amplification of endothelial activation by neutrophil products.
Vercellotti GM; Moldow CF; Wickham NW; Jacob HS
J Lipid Mediat; 1990; 2 Suppl():S23-30. PubMed ID: 1966817
[TBL] [Abstract][Full Text] [Related]
20. PMNs primed for superoxide release and increased CD11b expression do not sequester in normal lung.
Fontes B; Moore EE; Moore FA; Koike K; Carl V; Banerjee A
J Surg Res; 1995 Jun; 58(6):599-604. PubMed ID: 7791334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
